ARCT Earnings — Arcturus Therapeutics Holdings Inc. Common Stock Post-ER Performance | BigEarnings
ARCT — Arcturus Therapeutics Holdings Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$7.92
Market Cap$225.1M
P/E—
52W Range$5.85 – $24.17
Next Earnings2026-08-10
About Arcturus Therapeutics Holdings Inc. Common Stock
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
